Prasco Ships Sodium Sulfacetamide Lotion 10%, the Authorized Generic of Klaron®

 – Sodium Sulfacetamide Lotion 10% is AB-Rated to sanofi-aventis’ Klaron

CINCINNATI; January 16, 2007—Prasco Laboratories, a Cincinnati-based generic pharmaceutical company, announced today it has begun shipping Sodium Sulfacetamide Lotion 10%, the authorized generic of sanofi-aventis’ Klaron®1. Sodium Sulfacetamide Lotion 10% is AB-rated to Klaron and is
indicated in the topical control of acne vulgaris.

“We are excited about the expansion of the Prasco dermatological product line with the Sodium Sulfacetamide Lotion 10% product,” said Prasco vice president of communications & marketing services, Kimberly Carroll. “As a Prasco Authorized Generic, Sodium Sulfacetamide Lotion 10% will provide patients with the identical experience, quality and features as the brand product.” Carroll concluded.

About Sodium Sulfacetamide lotion
Sodium Sulfacetamide lotion 10% is indicated in the topical treatment of acne vulgaris. Adverse reactions in clinical trials were infrequent and, as with other drugs used in the topical treatment of acne, were restricted to local irritation, stinging, and burning. Severe reactions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, have occurred with suflonamides.

About Prasco
Sodium Sulfacetamide Lotion 10% is the latest product from Prasco in its rapidly growing Authorized Generics program. Prasco’s mission is to provide both quality products and significant cost-savings to the consumer. Our goal is to provide patients with an identical brand experience through Prasco Authorized Generics, which are generic products manufactured by brand companies and marketed as generics under the Prasco label. The Prasco product line is currently sold through the major distribution channels, including chains, independent pharmacies, distributors, wholesalers, and managed care providers.

###

CONTACT:
Kimberly Carroll, Vice President Communications & Marketing Services
Prasco Laboratories
513-618-3333
website: www.prasco.com
www.authorizedgenerics.com

1 Klaron,® is a registered trademark.

Search

Recent Posts

Prasco Launches Authorized Generic of ZIOPTAN® Ophthalmic Solution

MASON, Ohio; November 18, 2022 Prasco Laboratories announced today the launch of the Authorized Generic of ZIOPTAN® (tafluprost ophthalmic solution) 0.0015%. This is Prasco’s first Authorized Generic launch in partnership with Théa Pharma, Inc. Prasco’s Tafluprost...